Literature DB >> 304459

Mode of action of a soluble immune response suppressor (SIRS) produced by concanavalin a-activated spleen cells.

T Tadakuma, C W Pierce.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 304459

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  16 in total

1.  Effect of Bacillus Calmette-Guérin on the in vitro generation of cytotoxic T lymphocytes. II. Role of interleukin-1-like factors and of soluble suppressor factors.

Authors:  L Mellow; E Sabbadini
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

2.  Suppression of in-vitro antibody production by pokeweed mitogen-stimulated human bone-marrow mononuclear cells. Evidence for a soluble suppressor substance.

Authors:  C D Alley; R P MacDermott; G S Nash; M J Bertovich
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

3.  Activation of a suppressor T-cell pathway by interferon.

Authors:  T M Aune; C W Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

4.  Suppression of the polyclonal B-cell response to lipopolysaccharide by concanavalin-A-treated non-T cells in vitro.

Authors:  T Matsumoto; M Nakano; M Shibata
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

5.  Further study on the humoral response of a highly-purified spleen-derived immunosuppressive peptide (SDIP).

Authors:  N Duchange; L Millerioux; M Lenfant
Journal:  Immunology       Date:  1981-10       Impact factor: 7.397

6.  Suppression of polyclonal immunoglobulin biosynthesis by a soluble factor: T-cell dependent and T-cell independent mitogens.

Authors:  R S Krakauer; M K Cathcart; D N Ilfeld
Journal:  Immunology       Date:  1980-05       Impact factor: 7.397

7.  Macrophages: modulators of immunity. Parke-Davis Award Lecture.

Authors:  C W Pierce
Journal:  Am J Pathol       Date:  1980-01       Impact factor: 4.307

8.  Conversion of soluble immune response suppressor to macrophage-derived suppressor factor by peroxide.

Authors:  T M Aune; C W Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

9.  Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions.

Authors:  J Laurence; A B Gottlieb; H G Kunkel
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

10.  Characteristics of suppressor factors generated from human mononuclear cells using concanavalin A and C-reactive protein.

Authors:  A G Wangel; S Kontiainen
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.